The ERBB2 mRNA level was observably higher in the bladder, brain and CNS, breast, and pancreatic cancer tissues and signally lower in the colorectal, esophageal, head and neck, kidney, lung, lymphoma, and sarcoma cancers compared with the corresponding normal tissues. The gene discussed is ERBB2; the disease is familial pancreatic carcinoma.